Neurotech International (NTI) has launched an Authorised Prescriber program for NTI164 – a low-THC, broad-spectrum oral […]
Neurotech International (NTI) has launched an Authorised Prescriber program for NTI164 – a low-THC, broad-spectrum oral […]